Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer.

Details

Language :

English

ISSN :

03445704

Volume :

70

Issue :

2

Database :

Complementary Index

Journal :

Cancer Chemotherapy & Pharmacology

Publication Type :

Academic Journal

Accession number :

104482801

Full Text :

https://doi.org/10.1007/s00280-012-1914-y